Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase

Diego Botero, Balazs Gereben, Carla Goncalves, Lucia A. De Jesus, John W. Harney, Antonio C. Bianco

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The type 2 monodeiodinase (D2) is an endoplasmic reticulum-resident membrane selenoprotein responsible for catalyzing the first step in thyroid hormone action, T4 deiodination to T3. Its short half-life is due to ubiquitination and proteolysis by proteasomes, a mechanism that is accelerated by D2 interaction with T4. To identify proteins involved in D2 ubiquitination, a FLAG-tagged selenocystine133-to-Cys mutation of the human D2 (CysD2) was created and expressed in Saccharomyces cerevisiae using the GAL1 gene promoter. CysD2 activity was detected in the microsomes, indistinguishable from transiently expressed CysD2 in vertebrate cells. Treatment with 100 mg/ml cycloheximide or 30 μM T4 caused rapid loss of CysD2 (t1/2 = ∼30 min). Clasto-lactacystin β-lactone not only increased galactose-inducible CysD2 but also stabilized CysD2 in the presence of cycloheximide or T4. Immunoprecipitation with anti-FLAG antibody combined with Western analysis with antiubiquitin revealed that CysD2 is heavily ubiquitinated. Expression of CysD2 in yeast strains that lack the ubiquitin conjugases Ubc6p or Ubc7p stabilized CysD2 half-life by markedly reducing CysD2 ubiquitination, whereas no difference was detected in Ubc1p-deficient mutants. Similarly, expression of CysD2 in UBC6 and UBC7 mutants also impaired the substrate-induced loss of CysD2 activity and protein. In conclusion, Ubc6p and Ubc7p are required for normal and substrate-induced ubiquitination and proteolysis of D2.

Original languageEnglish
Pages (from-to)1999-2007
Number of pages9
JournalMolecular Endocrinology
Volume16
Issue number9
DOIs
StatePublished - Sep 1 2002

Fingerprint

Endoplasmic Reticulum-Associated Degradation
Selenoproteins
Iodide Peroxidase
Ubiquitination
Cycloheximide
Proteolysis
Half-Life
gamma-Glutamyl Hydrolase
Lactones
Proteasome Endopeptidase Complex
Ubiquitin
Microsomes
Galactose
Thyroxine
Immunoprecipitation
Endoplasmic Reticulum
Saccharomyces cerevisiae
Vertebrates
Anti-Idiotypic Antibodies
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. / Botero, Diego; Gereben, Balazs; Goncalves, Carla; De Jesus, Lucia A.; Harney, John W.; Bianco, Antonio C.

In: Molecular Endocrinology, Vol. 16, No. 9, 01.09.2002, p. 1999-2007.

Research output: Contribution to journalArticle

Botero, Diego ; Gereben, Balazs ; Goncalves, Carla ; De Jesus, Lucia A. ; Harney, John W. ; Bianco, Antonio C. / Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. In: Molecular Endocrinology. 2002 ; Vol. 16, No. 9. pp. 1999-2007.
@article{60ad702bbfdd4f9c935d95c5715662ec,
title = "Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase",
abstract = "The type 2 monodeiodinase (D2) is an endoplasmic reticulum-resident membrane selenoprotein responsible for catalyzing the first step in thyroid hormone action, T4 deiodination to T3. Its short half-life is due to ubiquitination and proteolysis by proteasomes, a mechanism that is accelerated by D2 interaction with T4. To identify proteins involved in D2 ubiquitination, a FLAG-tagged selenocystine133-to-Cys mutation of the human D2 (CysD2) was created and expressed in Saccharomyces cerevisiae using the GAL1 gene promoter. CysD2 activity was detected in the microsomes, indistinguishable from transiently expressed CysD2 in vertebrate cells. Treatment with 100 mg/ml cycloheximide or 30 μM T4 caused rapid loss of CysD2 (t1/2 = ∼30 min). Clasto-lactacystin β-lactone not only increased galactose-inducible CysD2 but also stabilized CysD2 in the presence of cycloheximide or T4. Immunoprecipitation with anti-FLAG antibody combined with Western analysis with antiubiquitin revealed that CysD2 is heavily ubiquitinated. Expression of CysD2 in yeast strains that lack the ubiquitin conjugases Ubc6p or Ubc7p stabilized CysD2 half-life by markedly reducing CysD2 ubiquitination, whereas no difference was detected in Ubc1p-deficient mutants. Similarly, expression of CysD2 in UBC6 and UBC7 mutants also impaired the substrate-induced loss of CysD2 activity and protein. In conclusion, Ubc6p and Ubc7p are required for normal and substrate-induced ubiquitination and proteolysis of D2.",
author = "Diego Botero and Balazs Gereben and Carla Goncalves and {De Jesus}, {Lucia A.} and Harney, {John W.} and Bianco, {Antonio C.}",
year = "2002",
month = "9",
day = "1",
doi = "10.1210/me.2002-0135",
language = "English",
volume = "16",
pages = "1999--2007",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Ubc6p and Ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase

AU - Botero, Diego

AU - Gereben, Balazs

AU - Goncalves, Carla

AU - De Jesus, Lucia A.

AU - Harney, John W.

AU - Bianco, Antonio C.

PY - 2002/9/1

Y1 - 2002/9/1

N2 - The type 2 monodeiodinase (D2) is an endoplasmic reticulum-resident membrane selenoprotein responsible for catalyzing the first step in thyroid hormone action, T4 deiodination to T3. Its short half-life is due to ubiquitination and proteolysis by proteasomes, a mechanism that is accelerated by D2 interaction with T4. To identify proteins involved in D2 ubiquitination, a FLAG-tagged selenocystine133-to-Cys mutation of the human D2 (CysD2) was created and expressed in Saccharomyces cerevisiae using the GAL1 gene promoter. CysD2 activity was detected in the microsomes, indistinguishable from transiently expressed CysD2 in vertebrate cells. Treatment with 100 mg/ml cycloheximide or 30 μM T4 caused rapid loss of CysD2 (t1/2 = ∼30 min). Clasto-lactacystin β-lactone not only increased galactose-inducible CysD2 but also stabilized CysD2 in the presence of cycloheximide or T4. Immunoprecipitation with anti-FLAG antibody combined with Western analysis with antiubiquitin revealed that CysD2 is heavily ubiquitinated. Expression of CysD2 in yeast strains that lack the ubiquitin conjugases Ubc6p or Ubc7p stabilized CysD2 half-life by markedly reducing CysD2 ubiquitination, whereas no difference was detected in Ubc1p-deficient mutants. Similarly, expression of CysD2 in UBC6 and UBC7 mutants also impaired the substrate-induced loss of CysD2 activity and protein. In conclusion, Ubc6p and Ubc7p are required for normal and substrate-induced ubiquitination and proteolysis of D2.

AB - The type 2 monodeiodinase (D2) is an endoplasmic reticulum-resident membrane selenoprotein responsible for catalyzing the first step in thyroid hormone action, T4 deiodination to T3. Its short half-life is due to ubiquitination and proteolysis by proteasomes, a mechanism that is accelerated by D2 interaction with T4. To identify proteins involved in D2 ubiquitination, a FLAG-tagged selenocystine133-to-Cys mutation of the human D2 (CysD2) was created and expressed in Saccharomyces cerevisiae using the GAL1 gene promoter. CysD2 activity was detected in the microsomes, indistinguishable from transiently expressed CysD2 in vertebrate cells. Treatment with 100 mg/ml cycloheximide or 30 μM T4 caused rapid loss of CysD2 (t1/2 = ∼30 min). Clasto-lactacystin β-lactone not only increased galactose-inducible CysD2 but also stabilized CysD2 in the presence of cycloheximide or T4. Immunoprecipitation with anti-FLAG antibody combined with Western analysis with antiubiquitin revealed that CysD2 is heavily ubiquitinated. Expression of CysD2 in yeast strains that lack the ubiquitin conjugases Ubc6p or Ubc7p stabilized CysD2 half-life by markedly reducing CysD2 ubiquitination, whereas no difference was detected in Ubc1p-deficient mutants. Similarly, expression of CysD2 in UBC6 and UBC7 mutants also impaired the substrate-induced loss of CysD2 activity and protein. In conclusion, Ubc6p and Ubc7p are required for normal and substrate-induced ubiquitination and proteolysis of D2.

UR - http://www.scopus.com/inward/record.url?scp=0036715341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036715341&partnerID=8YFLogxK

U2 - 10.1210/me.2002-0135

DO - 10.1210/me.2002-0135

M3 - Article

VL - 16

SP - 1999

EP - 2007

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 9

ER -